Nath Bio-Genes (India) logo

Nath Bio-Genes (India) financials and balance sheet

NSE: NATHBIOGENBSE: 537291Agricultural Food & other ProductsSmall Cap

Last close ₹130.52up ₹0.15 (0.12%)BSE ₹127.85

Share price at the NSE close on 23 Oct 2026. Previous close ₹130.37.

52-week range of traded prices to 23 Oct 2026
₹126.15Low, 30 Mar 2026₹204.00High, 30 Apr 2026
Market cap
₹248 Cr2,134th largest listed
P/E
6.8
P/E without one-offs
8.4
P/B
0.4
Dividend yield
1.53%
ROE
5.5%
ROE without one-offs
4.4%
ROCE
5.5%
Debt to equity
0.20
Volume, NSE
8,55672.5% delivered

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Nath Bio-Genes (India) annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹432 Cr, year to Mar 2026A loss in 1 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue432
  2. Materials and goods−191
  3. Employee costs−33
  4. Other expenses−154
  5. Operating profit53
  6. Depreciation−3.9
  7. Other income+7.8
  8. One-off items+6.0
  9. Finance costs−13
  10. Profit before tax49
  11. Tax−4.7
  12. Net profit44

What the company owns

  • Plant, investments and other assets₹484 Cr
  • Inventory₹445 Cr
  • Receivables₹84 Cr
  • Cash and bank₹71 Cr

What pays for it: net worth and liabilities

  • Net worth₹689 Cr
  • Other liabilities₹141 Cr
  • Owed to suppliers₹131 Cr
  • Borrowings₹122 Cr

Profit and loss

Standalone, ₹ crore, years to March.Nath Bio-Genes (India) quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 10 JunMar 2020Filed 15 JunMar 2021Filed 24 JunMar 2022Filed 27 JunMar 2023Filed 22 AprMar 2024Filed 10 MayMar 2025Filed 10 JunMar 2026Filed 4 May
Revenue from operations170192231280308278301333362432
141151188225241241253282309379
Materials and goods bought7184106126136124135134133191
Employee costs––1619242523283033
Other expenses––6680819295121146154
Operating profit before depreciation29404355673749505353
Operating margin17.0%21.1%18.7%19.5%21.7%13.4%16.2%15.1%14.6%12.2%
Materials, % of revenue––45.7%45.1%44.2%44.5%44.7%40.2%36.8%44.3%
Employee costs, % of revenue––7.1%6.7%7.7%8.9%7.7%8.4%8.4%7.7%
Other expenses, % of revenue––28.4%28.7%26.4%33.2%31.4%36.3%40.2%35.8%
Depreciation and amortisation3111333344
Operating profit after depreciation26394253643446474949
Other income1122221158
Finance costs1010579111091013
Profit before one-off items and tax–303949572536394443
One-off items––000−890306
Profit before tax1730394957−6336424449
010−2141225
Share of profit of joint ventures and associates––––––0–––
Net profit1629385056−6735404244
Other comprehensive income––00000100
Total comprehensive income––385056−6735414245
Net margin9.6%15.4%16.6%18.0%18.1%−24.2%11.6%12.1%11.6%10.3%
Net margin without joint ventures and associates––––––11.6%–––
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2017 and Mar 2018 they do not, so they are left blank.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 10 JunMar 2020Filed 15 JunMar 2021Filed 24 JunMar 2022Filed 27 JunMar 2023Filed 22 AprMar 2024Filed 10 MayMar 2025Filed 10 JunMar 2026Filed 4 May
508558613542573611649689
Share capital1919191919191919
Reserves489539594523554592630670
58709593105108111122
136170173197216261363388
23333656
Total assets6467307907427938771,0171,083
239253266272272309336319
407477524470521569681764
Net debt3648668967332451
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Filed 24 JunMar 2022Filed 27 JunMar 2023Filed 22 AprMar 2024Filed 10 MayMar 2025Filed 10 JunMar 2026Filed 4 May
117387527−14
−710487415−20
−66711420−33−73
Receivables−222123−41
Inventories−22612−21−102−114
Payables−2320−15143752
Other working capital−192352435−12
Tax paid0−310−1−1
Interest paid911−1001013
Capital spending4122783
Free cash flow−316364819−17
−10−20−3−27−43
16−22−2−10−11−7
Dividends paid044444
Shares bought back000000
Shares issued000000
Net change in cash7−25343812−17
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.Nath Bio-Genes (India) dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 10 JunMar 2020Filed 15 JunMar 2021Filed 24 JunMar 2022Filed 27 JunMar 2023Filed 22 AprMar 2024Filed 10 MayMar 2025Filed 10 JunMar 2026Filed 4 May
Earnings per share₹10.17₹15.48₹20.22₹26.33₹29.29−₹35.43₹18.42₹21.63₹22.00₹23.42
Diluted earnings per share₹10.17₹15.48₹20.22₹26.33₹29.29−₹35.43₹18.42₹21.63₹22.00₹23.42
Dividend per share––––₹2.00₹2.00₹2.00₹2.00₹2.00₹2.00
Book value per share––₹267.09₹293.42₹322.71₹285.19₹301.61₹321.33₹341.33₹362.75
Dividend payout––––6.8%–10.9%9.5%9.0%8.6%
Shareholder yield––––0.0%0.9%1.4%1.1%1.4%1.6%
Market cap at the year end (₹ crore)237658876257571405268331277245
RatioMar 2017Mar 2018Mar 2019Filed 10 JunMar 2020Filed 15 JunMar 2021Filed 24 JunMar 2022Filed 27 JunMar 2023Filed 22 AprMar 2024Filed 10 MayMar 2025Filed 10 JunMar 2026Filed 4 May
Revenue growth–12.9%20.5%21.2%9.9%−9.5%8.3%10.4%8.9%19.1%
Operating profit growth–39.9%7.1%26.5%22.0%−44.2%30.9%3.4%4.9%−0.6%
Net profit growth–80.7%30.6%31.4%10.3%––14.7%4.9%5.4%
Earnings per share growth–52.2%30.6%30.2%11.2%––17.4%1.7%6.5%
––7.6%9.5%9.5%−11.7%6.3%6.8%6.7%6.6%
–––1.9 pts0.0 pts−21.2 pts17.9 pts0.5 pts−0.1 pts−0.1 pts
From the net margin–––0.6 pts0.0 pts−22.2 pts17.3 pts0.2 pts−0.3 pts−0.8 pts
From asset turnover–––1.1 pts0.0 pts1.3 pts0.4 pts0.1 pts−0.3 pts0.4 pts
From borrowing–––0.1 pts0.0 pts−0.2 pts0.2 pts0.2 pts0.4 pts0.3 pts
Return on capital employed––7.4%8.5%9.0%5.4%6.7%6.6%6.5%6.0%
Cash conversion––––2.0%–109.5%186.0%63.8%−31.3%
Interest cover2.73.88.08.17.23.24.55.25.13.7
Debt to equity––0.110.130.150.170.180.180.170.18
Receivable days––1711401301151181038971
Inventory days––537591607649564626905848
Payable days––17319712116275115215249
Cash conversion cycle, days––534533615602606615779670
Working capital days––485463494474450371342361
Asset turnover––0.360.410.400.360.390.400.380.41
Assets per rupee of net worth––1.271.291.301.331.381.411.501.57
Sales per rupee of plant––1.011.211.321.201.291.381.491.77
Capital spending to depreciation––––1.350.360.828.212.040.76
Plant being built, % of plant in use––0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
4.2%
Cash from operations against operating profit
−26.5%
Measure10 years5 years3 years
Revenue growth, yearly rate–7.0%12.7%
Profit growth, yearly rate–−4.4%8.2%
Return on equity, average–2.9%6.7%
Return on capital employed, average–6.2%6.3%
Operating margin, average16.9%14.3%14.0%
Net margin, average9.9%4.3%11.3%
Asset turnover, average–0.390.40
Cash conversion cycle, days, average–654688
Interest cover, average5.24.34.6
Debt to equity, average–0.180.18

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations14388−14
Cash from investing−51−283
Cash from financing−51−27−7
Capital spending41383
Dividends paid19114
Shares bought back000
Shares issued for cash000
Borrowings raised770
Borrowings repaid311611

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––5387––
Altman Z-scorePublished threshold 1.81––5.943.074.192.79––––
Beneish M-scorePublished threshold −1.78––––−2.00−3.17−2.44–––
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––8.53−8.43−0.06–––
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––2.4216.55––
Receivables growth less revenue growthOur threshold 0 percentage points–––−22.15−7.65−10.132.42–––
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––12.012.976.28−14.26–––
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––1.98−1.831.4156.45–––
Assets under construction, years of additionsOur threshold 2 years of additions–––0.000.000.000.00–––
Effective tax ratePublished threshold 17.16 per cent2.812.121.12−4.071.92–––––
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
1 Sep 2026India Ratings and Research Private Limited (opens in a new tab)Bank loan facilitiesIND BBB+; IND A2New, NewStable45
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.